{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:53:14Z","timestamp":1790902394960,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4540,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1111\/j.1600-6143.2010.03152.x","type":"journal-article","created":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T10:47:51Z","timestamp":1277462871000},"page":"1710-1715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?"],"prefix":"10.1016","volume":"10","author":[{"given":"G.","family":"Canaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Knebelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vrtovsnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010M.","family":"Correas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M","family":"Heyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Letavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bienaim\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2010.03152.x_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib2","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: The last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease","volume":"3","author":"Edelstein","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib6","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin\u20101, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib9","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal\u2010dominant polycystic kidney disease (ADPKD): The consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","article-title":"Volumetric measurement of renal cysts and parenchyma using MRI: Phantoms and patients with polycystic kidney disease","volume":"24","author":"Bae","year":"2000","journal-title":"J Comput Assist Tomogr"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib12","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/0008-5472.CAN-3554-2","article-title":"Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells","volume":"64","author":"Boulay","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib14","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1523-1755.2005.00731.x","article-title":"Biochemical monitoring of mTOR inhibitor\u2010based immunosuppression following kidney transplantation: A novel approach for tailored immunosuppressive therapy","volume":"68","author":"Hartmann","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib16","first-page":"378","article-title":"Successful use of cadaver kidneys from diabetic donors for transplantation","volume":"22","author":"Spees","year":"1990","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib17","first-page":"376","article-title":"Transplant of a polycystic kidney because of organ shortage","volume":"22","author":"Mancini","year":"1990","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00007890-199212000-00042","article-title":"The polycystic kidney donor","volume":"54","author":"Siegal","year":"1992","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/ndt\/16.2.410","article-title":"Polycystic kidney patient as a cadaveric donor: Is it appropriate?","volume":"16","author":"Shan","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.transproceed.2004.05.003","article-title":"Transplantation of a cadaveric polycystic kidney in a patient with autosomal dominant polycystic kidney disease: Long\u2010term outcome","volume":"36","author":"Powell","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/00007890-199911270-00034","article-title":"Development of polycystic disease in a kidney 10 years after transplantation","volume":"68","author":"Howard","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of PKD1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nm.2068","article-title":"A mitotic transcriptional switch in polycystic kidney disease","volume":"16","author":"Verdeguer","year":"2010","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han: SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib26","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.tp.0000178393.78084.9b","article-title":"Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function","volume":"80","author":"Russ","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo","volume":"2","author":"Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03152.x_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)80116-6","article-title":"The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors","volume":"86","author":"Wang","year":"1996","journal-title":"Cell"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2010.03152.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522126511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522126511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2010.03152.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:49:31Z","timestamp":1761626971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522126511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1600613522126511"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03152.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03152.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}